Ítem
Solo Metadatos
Autoimmunity co-signaling system: Regulatory T cells, CTLA-4 and FOXP3
dc.creator | Gómez Osorio L.M. | spa |
dc.creator | Martín Ibañez J. | spa |
dc.creator | Anaya, Juan-Manuel | spa |
dc.date.accessioned | 2020-05-26T00:11:36Z | |
dc.date.available | 2020-05-26T00:11:36Z | |
dc.date.created | 2005 | spa |
dc.description.abstract | Co-signaling molecules can act as co-stimulators or co-inhibitors, depending on whether they promote or suppress T-cell activation, respectively. At the specific time and location, co-signaling molecules positively and negatively control antigen presentation, growth, differentiation and function of T-cells. An important cellular group implicated in the regulation of co-stimulation is known as regulatory T cells (Treg). These cells can be used clinically in treatments ranging from cellular transfer in transplant patients to autoimmune diseases and suppression in cancer patients. Treg act through CTLA-4 molecules, which have the ability to suppress the co-stimulation signals and to stop the T cell response. Recently, CTLA-4Ig fusion molecules have been developed, which can block the presentation of auto-antigens. FOXP3 transcription factor is a specific molecule present in Treg that inhibits the production of IL-2 by CD4+ activated cells. Currently, FOXP3 functions are being extensively studied in order to develop new therapeutic targets. This article reviews co-signaling and its mechanism in Treg (CTLA-4, FOXP3), as well as its role in the physiopathology of autoimmune diseases. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/24315 | |
dc.language.iso | eng | spa |
dc.relation.citationEndPage | 297 | |
dc.relation.citationIssue | No. 3 | |
dc.relation.citationStartPage | 283 | |
dc.relation.citationTitle | Inmunologia | |
dc.relation.citationVolume | Vol. 24 | |
dc.relation.ispartof | Inmunologia, Vol.24, No.3 (2005); pp. 283-297 | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-29444445787&partnerID=40&md5=1e4580a5c4146c14f1a849d44ab7c38d | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Cytotoxic T lymphocyte antigen 4 | spa |
dc.subject.keyword | Transcription factor FOXP3 | spa |
dc.subject.keyword | Antigen presentation | spa |
dc.subject.keyword | Autoimmunity | spa |
dc.subject.keyword | Cell differentiation | spa |
dc.subject.keyword | Cell function | spa |
dc.subject.keyword | Cell stimulation | spa |
dc.subject.keyword | Gene repression | spa |
dc.subject.keyword | Genetic transcription | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | Molecular dynamics | spa |
dc.subject.keyword | Nonhuman | spa |
dc.subject.keyword | Promoter region | spa |
dc.subject.keyword | Review | spa |
dc.subject.keyword | Signal transduction | spa |
dc.subject.keyword | T lymphocyte | spa |
dc.subject.keyword | Autoimmune Diabetes | spa |
dc.subject.keyword | Autoimmunity | spa |
dc.subject.keyword | Co-signaling | spa |
dc.subject.keyword | CTLA-4 | spa |
dc.subject.keyword | FOXP3 | spa |
dc.subject.keyword | Regulatory T cells | spa |
dc.subject.keyword | Rheumatoid Arthritis | spa |
dc.subject.keyword | Systemic Lupus Erythematosus | spa |
dc.title | Autoimmunity co-signaling system: Regulatory T cells, CTLA-4 and FOXP3 | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |